C Aul
Overview
Explore the profile of C Aul including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
174
Citations
2405
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nachtkamp K, Strupp C, Vukelja M, Kasprzak A, Haase D, Ganster C, et al.
Leukemia
. 2024 Jan;
38(2):442-445.
PMID: 38263435
No abstract available.
2.
3.
Schuler E, Frank F, Hildebrandt B, Betz B, Strupp C, Rudelius M, et al.
Leuk Res
. 2017 Dec;
65:1-4.
PMID: 29216536
MDS patients may present with monocytic marrow proliferation not fulfilling criteria for CMML. We analyzed MDS patients with or without a marrow monocytic proliferation by following up the amount of...
4.
Krug U, Berdel W, Gale R, Haferlach C, Schnittger S, Muller-Tidow C, et al.
Leukemia
. 2016 Feb;
30(6):1230-6.
PMID: 26859081
We randomized 3375 adults with newly diagnosed acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome to test whether increasingly intensive chemotherapies assigned at study-entry and analyzed on an intent-to-treat basis...
5.
Gratwohl A, Pfirrmann M, Zander A, Kroger N, Beelen D, Novotny J, et al.
Leukemia
. 2015 Oct;
30(3):562-9.
PMID: 26464170
Tyrosine kinase inhibitors represent today's treatment of choice in chronic myeloid leukemia (CML). Allogeneic hematopoietic stem cell transplantation (HSCT) is regarded as salvage therapy. This prospective randomized CML-study IIIA recruited...
6.
Schanz J, Tuchler H, Sole F, Mallo M, Luno E, Cervera J, et al.
Leukemia
. 2013 Jun;
27(10):1988-95.
PMID: 23787396
Monosomal karyotype (MK) is associated with an adverse prognosis in patients in acute myeloid leukemia (AML). This study analyzes the prognostic impact of MK in a cohort of primary, untreated...
7.
Germing U, Lauseker M, Hildebrandt B, Symeonidis A, cermak J, Fenaux P, et al.
Leukemia
. 2012 Feb;
26(6):1286-92.
PMID: 22289990
Myelodysplastic syndromes (MDS) with del(5q) are considered to have a benign course of the disease. In order to address the issue of the propensity of those patients to progress to...
8.
Giagounidis A, Kulasekararaj A, Germing U, Radkowski R, Haase S, Petersen P, et al.
Leukemia
. 2011 Oct;
26(4):855-8.
PMID: 21960245
No abstract available.
9.
Germing U, Sohngen D, Heyll A, Kobbe G, Aul C, Schneider W
Oncol Rep
. 2011 May;
3(4):775-6.
PMID: 21594453
Allogeneic BMT was performed in a 33-year-old man because of CML. Donor was his HLA-identical brother. GVHD prophylaxis consisted of short-term MTX and i.v. CsA. On day 17 cutaneous GVHD...
10.
Kobbe G, Heyll A, Zodler T, Sohngen D, Aul C, Thiele K, et al.
Oncol Rep
. 2011 May;
4(4):823-4.
PMID: 21590149
Acalculous cholecystitis (AAC) is a well known complication in critically ill patients. Risk factors include mechanical ventilation, total parenteral nutrition and multiple blood transfusions. AAC has very rarely been described...